Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report

Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report

Jiamo Li,1 Jianing Jiang,1,2 Jinyan Lv,1 Ru Zhang,1 Wenting Chen,1,2 Shiyi Li,1 Qianchen Jin,1 Gang Wang1,2 1Department of Medical Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, People’s Republic of China; 2The Key Laboratory of Biomarker, High-Throughpu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li J, Jiang J, Lv J, Zhang R, Chen W, Li S, Jin Q, Wang G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
anti-gababr antibody
autoimmune encephalitis
immunotherapies
small cell lung cancer
durvalumab
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/715ea3d186ce4717aa84511ac7a29517
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/715ea3d186ce4717aa84511ac7a29517

Ejemplares similares